Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 8 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026 and Aug 2026.
- Largest single sale: $4.7M (108,759 shares) of Royalty Pharma plc on Feb 3, 2026. Filing
- Last sale before this period: Aug 10, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Royalty Pharma plc (RPRX) | EVP & CFO | Jun 15, 2020 | Aug 17, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 13, 2026, Royalty Pharma plc: sold 11,002 shares for $646K, under a disclosed plan (some held indirectly). 1 filing: 1
- Aug 7, 2026, Royalty Pharma plc: 18,500 shares given away (some held indirectly). 1 filing: 1
- Aug 5, 2026, Royalty Pharma plc: 11,002 shares awarded (some held indirectly). 1 filing: 1
- May 26, 2026, Royalty Pharma plc: sold 64,399 shares for $3.5M, under a disclosed plan (some held indirectly). 1 filing: 1
- May 6, 2026, Royalty Pharma plc: 24,263 shares awarded (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.